Lv3
260 积分 2024-06-24 加入
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
14天前
已完结
Endothelin receptor antagonists in chronic kidney disease
14天前
已完结
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
14天前
已完结
Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta-analysis of randomized controlled trials
14天前
已完结
Erratum to “IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045” [Diabetes Res. Clin. Pract. 183 (2022) 109119]
1个月前
已完结
Primary Hyperoxaluria
1个月前
已完结
Diabetes Insipidus
1个月前
已完结
Mechanisms of prolonged lithium therapy-induced nephrogenic diabetes insipidus
1个月前
已完结
C-reactive protein-to-albumin ratio predicts outcome of neoadjuvant chemotherapy for colorectal liver metastases: A multicenter prediction model
2个月前
已完结
Glucocorticoid-Modulated Molecular Signatures and Prediction of Treatment Efficacy in IgA Nephropathy
2个月前
已完结